Page last updated: 2024-09-05

sb 203580 and Lymphocytopenia

sb 203580 has been researched along with Lymphocytopenia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blasco, F; Fu, Y; Hervé, M; Seah, PG; Shi, PY; Yip, A	1

Other Studies

1 other study(ies) available for sb 203580 and Lymphocytopenia

Article	Year
Modulation of inflammation and pathology during dengue virus infection by p38 MAPK inhibitor SB203580. Antiviral research, 2014, Volume: 110 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Capillary Permeability; Cell Line; Chemokine CCL5; Cricetinae; Culicidae; Dengue; Dengue Virus; Enzyme Inhibitors; Hematocrit; Humans; Imidazoles; Inflammation; Interleukin-8; Lymphopenia; Mice; p38 Mitogen-Activated Protein Kinases; Pyridines; Tumor Necrosis Factor-alpha	2014

Article

Year

Modulation of inflammation and pathology during dengue virus infection by p38 MAPK inhibitor SB203580.

Antiviral research, 2014, Volume: 110

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Capillary Permeability; Cell Line; Chemokine CCL5; Cricetinae; Culicidae; Dengue; Dengue Virus; Enzyme Inhibitors; Hematocrit; Humans; Imidazoles; Inflammation; Interleukin-8; Lymphopenia; Mice; p38 Mitogen-Activated Protein Kinases; Pyridines; Tumor Necrosis Factor-alpha

2014